ACCORD Trademark

Trademark Overview


On Tuesday, August 30, 2022, a trademark application was filed for ACCORD with the United States Patent and Trademark Office. The USPTO has given the ACCORD trademark a serial number of 97570485. The federal status of this trademark filing is REGISTERED as of Tuesday, February 20, 2024. This trademark is owned by Accord Healthcare, Inc.. The ACCORD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, non-prescription and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of various medical conditions, in particular, gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension
accord

General Information


Serial Number97570485
Word MarkACCORD
Filing DateTuesday, August 30, 2022
Status700 - REGISTERED
Status DateTuesday, February 20, 2024
Registration Number7308256
Registration DateTuesday, February 20, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, non-prescription and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of various medical conditions, in particular, gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes052, 051, 005, 018, 006, 044, 046
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateThursday, May 19, 2005
First Use In Commerce DateSunday, January 1, 2006

Trademark Owner History


Party NameAccord Healthcare, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameAccord Healthcare, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Party NameAccord Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Tuesday, February 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 30, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 30, 2023EXAMINER'S AMENDMENT ENTERED
Monday, October 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023EXAMINERS AMENDMENT E-MAILED
Monday, October 30, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, October 30, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 30, 2023NON-FINAL ACTION E-MAILED
Monday, October 30, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, June 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, March 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NON-FINAL ACTION WRITTEN
Thursday, March 30, 2023ASSIGNED TO EXAMINER
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 2, 2022NEW APPLICATION ENTERED